Beond — Cancún, Mexico
Beond is an ibogaine treatment center located in Cancún, Mexico, describing itself as a hospital-grade neuroplasticity treatment center. The facility reports staffing ICU-certified nurses and licensed physicians, and conducts cardiac screening prior to treatment — a medically important step given ibogaine's known effects on cardiac conduction. Beond states it has treated more than 3,000 patients and is among the larger clinically resourced ibogaine facilities operating today. The clinic has announced plans to expand to Austin, Texas.
Conditions Addressed
- Opioid addiction
- Alcohol use disorder
- PTSD
- Depression
- Anxiety
- Traumatic brain injury (TBI)
- Personal growth
Pricing
| Price Range (USD) | Notes |
|---|---|
| $12,500 – $19,500 | Tiered pricing; the starting rate requires booking 90 or more days in advance |
What to Expect
Beond uses ibogaine, a psychoactive substance derived from the Tabernanthe iboga plant, in a supervised medical setting. Ibogaine is not approved by the FDA and remains a Schedule I controlled substance in the United States, which is why clinics offering it legally operate outside the country. Treatment stays are residential and take place in Cancún. The clinic emphasizes medical oversight throughout the process, including pre-treatment cardiac screening.
What to Research Before Committing
- Cardiac risk: Ibogaine carries documented risk of QT prolongation and cardiac arrhythmia. Ask specifically how cardiac clearance is conducted and who reviews results.
- Accreditation: No accreditations are listed for this facility. Ask whether staff credentials can be independently verified.
- Aftercare planning: Ibogaine treatment outcomes are heavily influenced by what follows the acute experience. Ask what aftercare resources or referrals are provided.
- Legal context: Understand the legal status of ibogaine in your home country before traveling for treatment.
- Tiered pricing structure: Clarify exactly what is included at each price tier and what the advance booking terms require.
Ibogaine carries serious cardiac risks and has been associated with fatalities. Medical screening before treatment is essential, not optional. Ensure any facility you consider has genuine emergency response capabilities.